Acer Therapeutics Inc. (ACER) Social Stream



Acer Therapeutics Inc. (ACER): $2.20

-0.06 (-2.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Acer Therapeutics Inc (ACER) Price Targets From Analysts

Use the tables below to see what analysts covering Acer Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $10 $10 $10 $2.62 281.68%

Price Target Last Issued September 20, 2021

The Trend in the Analyst Price Target


ACER's average price target has moved down $0 over the prior 170 days.

ACER reports an average of 254.1% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 1 10 10.00 10.00 2.52 296.83%
2021-09-19 1 10 10.00 10.00 2.46 306.5%
2021-09-18 1 10 10.00 10.00 2.46 306.5%
2021-09-11 1 10 10.00 10.00 2.68 273.13%
2021-09-04 1 10 10.00 10.00 2.67 274.53%
2021-08-28 1 10 10.00 10.00 2.54 293.7%
2021-08-14 1 10 10.00 10.00 2.45 308.16%
2021-08-07 1 10 10.00 10.00 2.60 284.62%
2021-08-05 1 10 10.00 10.00 2.42 313.22%
2021-08-01 1 10 10.00 10.00 2.56 290.62%
2021-07-24 1 10 10.00 10.00 2.50 300%
2021-07-17 1 10 10.00 10.00 2.40 316.67%
2021-07-10 1 10 10.00 10.00 2.62 281.68%
2021-07-03 1 10 10.00 10.00 2.86 249.65%
2021-06-26 1 10 10.00 10.00 2.98 235.57%
2021-06-13 2 10 10.00 10.00 3.10 222.58%
2021-06-05 2 10 10.00 10.00 3.00 233.33%
2021-05-22 2 10 10.00 10.00 2.89 246.02%
2021-05-15 2 10 10.00 10.00 2.63 280.23%
2021-05-08 2 10 10.00 10.00 2.72 267.65%
2021-04-25 2 10 10.00 10.00 2.92 242.47%
2021-04-17 2 10 10.00 10.00 2.72 267.65%
2021-04-10 2 10 10.00 10.00 3.02 231.13%
2021-04-03 2 10 10.00 10.00 3.18 214.47%
2021-03-20 2 10 10.00 10.00 3.46 189.02%
2021-03-13 2 10 10.00 10.00 3.41 193.26%
2021-03-06 2 10 10.00 10.00 2.87 248.43%
2021-02-27 2 10 10.00 10.00 3.15 217.46%
2021-02-20 2 10 10.00 10.00 3.58 179.33%
2021-02-13 2 10 10.00 10.00 3.84 160.42%
2021-02-06 2 10 10.00 10.00 3.99 150.63%
2021-01-30 2 10 10.00 10.00 3.65 173.97%
2021-01-23 2 10 10.00 10.00 3.67 172.48%
2021-01-16 2 10 10.00 10.00 3.85 159.74%
2021-01-09 2 10 10.00 10.00 2.49 301.61%
2021-01-02 2 10 10.00 10.00 2.62 281.68%
2020-12-26 2 10 10.00 10.00 2.65 277.36%
2020-12-19 2 10 10.00 10.00 2.69 271.75%
2020-12-09 2 10 10.00 10.00 2.34 327.35%
2020-12-07 2 10 10.00 10.00 2.55 292.16%
2020-11-28 2 10 10.00 10.00 2.60 284.62%
2020-09-09 2 10 10.00 10.00 NA NA%
2020-08-14 2 10 10.00 10.00 NA NA%
2020-07-29 3 10 3.52 7.84 NA NA%
2020-06-26 3 10 3.52 7.84 NA NA%
2020-05-15 3 10 3.52 7.17 NA NA%

ACER Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 0 1 1 0 0 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACER as an investment opportunity.

  • Acer Therapeutics Inc's number of analysts covering the stock is higher than practically none of all US stocks.
  • The variance in analysts' estimates of ACER is lower than nearly 100% of all US stocks.
  • Acer Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 92.84% of all US stocks.
  • ACER has a higher average analyst price target than 18.53% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Acer Therapeutics Inc are CLSN, BCLI and SNGX.

Make investment decisions regarding ACER using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.1497 seconds.